2022 Q3 Form 10-K Financial Statement
#000118518522001017 Filed on August 25, 2022
Income Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 |
---|---|---|---|
Revenue | $6.045M | $6.160M | $22.66M |
YoY Change | 9.89% | 1.66% | 17.47% |
Cost Of Revenue | $3.003M | $3.134M | $11.12M |
YoY Change | 15.29% | -0.75% | 15.34% |
Gross Profit | $3.042M | $3.026M | $11.54M |
YoY Change | 5.04% | 4.28% | 19.61% |
Gross Profit Margin | 50.33% | 49.12% | 50.92% |
Selling, General & Admin | $3.202M | $2.976M | $12.42M |
YoY Change | 10.58% | -3.5% | 14.96% |
% of Gross Profit | 105.26% | 98.35% | 107.61% |
Research & Development | $0.00 | $17.36K | |
YoY Change | -100.0% | -53.23% | |
% of Gross Profit | 0.0% | 0.15% | |
Depreciation & Amortization | $236.9K | $218.4K | $753.7K |
YoY Change | 33.63% | 25.33% | 9.99% |
% of Gross Profit | 7.79% | 7.22% | 6.53% |
Operating Expenses | $3.202M | $2.976M | $12.42M |
YoY Change | 10.58% | -3.5% | -6.64% |
Operating Profit | -$160.1K | $49.90K | -$877.9K |
YoY Change | -35678.89% | -127.37% | -75.96% |
Interest Expense | $766.7K | -$845.7K | $2.150M |
YoY Change | -283.16% | -40.44% | -41.22% |
% of Operating Profit | -1694.81% | ||
Other Income/Expense, Net | -$652.9K | $479.0K | |
YoY Change | -186.43% | -104.91% | |
Pretax Income | -$813.0K | -$273.6K | -$398.9K |
YoY Change | -207.55% | -96.44% | -97.02% |
Income Tax | $519.1K | $1.248M | $2.041M |
% Of Pretax Income | |||
Net Earnings | -$1.148M | -$1.433M | -$2.343M |
YoY Change | -368.59% | -85.93% | -85.25% |
Net Earnings / Revenue | -19.0% | -23.26% | -10.34% |
Basic Earnings Per Share | -$0.04 | -$0.02 | |
Diluted Earnings Per Share | -$0.04 | -$11.18K | -$0.02 |
COMMON SHARES | |||
Basic Shares Outstanding | 128.2M shares | 128.1M shares | |
Diluted Shares Outstanding | 32.05M shares | 128.1M shares |
Balance Sheet
Concept | 2022 Q3 | 2022 Q2 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $592.0K | $2.552M | $2.552M |
YoY Change | -69.81% | 53.24% | 53.24% |
Cash & Equivalents | $592.0K | $2.552M | $2.552M |
Short-Term Investments | |||
Other Short-Term Assets | $418.5K | $295.9K | $295.9K |
YoY Change | 61.22% | 12.79% | 17.26% |
Inventory | $4.216M | $3.418M | $3.418M |
Prepaid Expenses | $418.4K | $295.9K | |
Receivables | $739.2K | $618.2K | $618.2K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $5.966M | $6.884M | $6.884M |
YoY Change | 33.23% | 79.23% | 79.23% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $4.222M | $4.342M | $6.497M |
YoY Change | -24.61% | 24.94% | 13.47% |
Goodwill | $557.9K | $557.9K | |
YoY Change | 0.0% | ||
Intangibles | $1.162M | $1.190M | |
YoY Change | -8.8% | ||
Long-Term Investments | $1.040M | $469.6K | $469.6K |
YoY Change | |||
Other Assets | $219.0K | $229.5K | $229.5K |
YoY Change | 30.78% | 37.05% | 37.05% |
Total Long-Term Assets | $9.316M | $8.944M | $8.944M |
YoY Change | 22.55% | 15.32% | 15.32% |
TOTAL ASSETS | |||
Total Short-Term Assets | $5.966M | $6.884M | $6.884M |
Total Long-Term Assets | $9.316M | $8.944M | $8.944M |
Total Assets | $15.28M | $15.83M | $15.83M |
YoY Change | 26.51% | 36.48% | 36.48% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.671M | $1.414M | $1.414M |
YoY Change | 124.0% | 83.21% | 83.21% |
Accrued Expenses | $1.390M | $1.633M | $1.633M |
YoY Change | 16.58% | 17.3% | 17.3% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $1.153M | $1.013M | $1.013M |
YoY Change | |||
Long-Term Debt Due | $19.52M | $19.52M | $19.52M |
YoY Change | 5449.77% | 5806.39% | 5806.39% |
Total Short-Term Liabilities | $28.79M | $28.11M | $28.11M |
YoY Change | 463.48% | 463.99% | 463.99% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $3.146M | $2.971M | $2.971M |
YoY Change | -83.83% | -84.94% | -84.94% |
Other Long-Term Liabilities | $1.829M | $1.894M | $1.894M |
YoY Change | -4.25% | -4.32% | -4.32% |
Total Long-Term Liabilities | $4.974M | $4.865M | $4.865M |
YoY Change | -76.71% | -77.59% | -77.59% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $28.79M | $28.11M | $28.11M |
Total Long-Term Liabilities | $4.974M | $4.865M | $4.865M |
Total Liabilities | $33.76M | $32.98M | $32.88M |
YoY Change | 27.56% | 23.54% | 23.17% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$96.23M | -$95.08M | |
YoY Change | 2.53% | ||
Common Stock | $3.206K | $12.82K | |
YoY Change | 0.78% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$18.20M | -$17.05M | -$17.05M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $15.28M | $15.83M | $15.83M |
YoY Change | 26.51% | 36.48% | 36.48% |
Cashflow Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.148M | -$1.433M | -$2.343M |
YoY Change | -368.59% | -85.93% | -85.25% |
Depreciation, Depletion And Amortization | $236.9K | $218.4K | $753.7K |
YoY Change | 33.63% | 25.33% | 9.99% |
Cash From Operating Activities | -$1.462M | -$600.3K | -$3.158M |
YoY Change | 86.15% | 25.46% | 24.56% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $88.23K | -$938.9K | $1.105M |
YoY Change | -194.89% | 964.91% | 310.04% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$457.1K | -$39.01K | $2.097M |
YoY Change | -138.93% | 35.79% | |
Cash From Investing Activities | -$545.3K | -$977.9K | $992.3K |
YoY Change | -150.44% | 1009.03% | -22.17% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $47.25K | 675.5K | $3.052M |
YoY Change | |||
NET CHANGE | |||
Cash From Operating Activities | -$1.462M | -600.3K | -$3.158M |
Cash From Investing Activities | -$545.3K | -977.9K | $992.3K |
Cash From Financing Activities | $47.25K | 675.5K | $3.052M |
Net Change In Cash | -$1.960M | -902.7K | $886.6K |
YoY Change | -762.5% | 59.3% | -170.35% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.462M | -$600.3K | -$3.158M |
Capital Expenditures | $88.23K | -$938.9K | $1.105M |
Free Cash Flow | -$1.550M | $338.6K | -$4.262M |
YoY Change | 123.89% | -186.75% | 51.98% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-05-31 | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--05-31 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
000-55546 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
CLS HOLDINGS USA, INC. | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
45-1352286 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
11767 South Dixie Highway, Suite 115 | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Miami | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
33156 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
888 | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
438-9132 | |
CY2022 | dei |
Security12b Title
Security12bTitle
|
N/A | |
CY2022 | dei |
Trading Symbol
TradingSymbol
|
N/A | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2022 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2021Q4 | dei |
Entity Public Float
EntityPublicFloat
|
12503655 | usd |
CY2022Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
128208082 | shares |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
2738 | |
CY2022 | dei |
Auditor Name
AuditorName
|
M&K CPAS, PLLC | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Houston, TX | |
CY2022Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2551859 | usd |
CY2021Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1665263 | usd |
CY2022Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
618227 | usd |
CY2021Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
684935 | usd |
CY2022Q2 | us-gaap |
Inventory Net
InventoryNet
|
3417602 | usd |
CY2021Q2 | us-gaap |
Inventory Net
InventoryNet
|
1228052 | usd |
CY2022Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
295869 | usd |
CY2021Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
262313 | usd |
CY2022Q2 | us-gaap |
Assets Current
AssetsCurrent
|
6883557 | usd |
CY2021Q2 | us-gaap |
Assets Current
AssetsCurrent
|
3840563 | usd |
CY2022Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2073449 | usd |
CY2021Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1434614 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4342434 | usd |
CY2021Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3475668 | usd |
CY2022Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2154517 | usd |
CY2021Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2250009 | usd |
CY2022Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
473308 | usd |
CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
358403 | usd |
CY2022Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1190285 | usd |
CY2021Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1305190 | usd |
CY2022Q2 | us-gaap |
Goodwill
Goodwill
|
557896 | usd |
CY2021Q2 | us-gaap |
Goodwill
Goodwill
|
557896 | usd |
CY2022Q2 | us-gaap |
Other Long Term Investments
OtherLongTermInvestments
|
469575 | usd |
CY2021Q2 | us-gaap |
Other Long Term Investments
OtherLongTermInvestments
|
0 | usd |
CY2022Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
229500 | usd |
CY2021Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
167455 | usd |
CY2022Q2 | us-gaap |
Assets
Assets
|
15827764 | usd |
CY2021Q2 | us-gaap |
Assets
Assets
|
11596781 | usd |
CY2022Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2317898 | usd |
CY2021Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1608625 | usd |
CY2022Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
419206 | usd |
CY2021Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
267945 | usd |
CY2022Q2 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
1013073 | usd |
CY2021Q2 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
0 | usd |
CY2022Q2 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
71813 | usd |
CY2021Q2 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
0 | usd |
CY2022Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
309597 | usd |
CY2021Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
287125 | usd |
CY2022Q2 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
4531782 | usd |
CY2021Q2 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
2490295 | usd |
CY2022Q2 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
0 | usd |
CY2021Q2 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
35496 | usd |
CY2022Q2 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
19448821 | usd |
CY2021Q2 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
330495 | usd |
CY2022Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
28112190 | usd |
CY2021Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4984485 | usd |
CY2022Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1893810 | usd |
CY2021Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1979294 | usd |
CY2022Q2 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
277180 | usd |
CY2022Q2 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
1681434 | usd |
CY2021Q2 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
0 | usd |
CY2022Q2 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
2693566 | usd |
CY2021Q2 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
0 | usd |
CY2022Q2 | us-gaap |
Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
|
0 | usd |
CY2021Q2 | us-gaap |
Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
|
0 | usd |
CY2022Q2 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
0 | usd |
CY2021Q2 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
19729822 | usd |
CY2022Q2 | us-gaap |
Liabilities
Liabilities
|
32976746 | usd |
CY2021Q2 | us-gaap |
Liabilities
Liabilities
|
26693601 | usd |
CY2022Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
0 | usd |
CY2021Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
0 | usd |
CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2021Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2021Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
750000000 | shares |
CY2021Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
750000000 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
128208082 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
128208082 | shares |
CY2021Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
127221416 | shares |
CY2021Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
127221416 | shares |
CY2022Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
12822 | usd |
CY2021Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
12723 | usd |
CY2022Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
77945132 | usd |
CY2021Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
77561393 | usd |
CY2022Q2 | clsh |
Stock Payable
StockPayable
|
70092 | usd |
CY2021Q2 | clsh |
Stock Payable
StockPayable
|
65702 | usd |
CY2022Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-95079817 | usd |
CY2021Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-92736638 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-17051771 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-15096820 | usd |
CY2022Q2 | us-gaap |
Minority Interest
MinorityInterest
|
-97211 | usd |
CY2021Q2 | us-gaap |
Minority Interest
MinorityInterest
|
0 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-17148982 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-15096820 | usd |
CY2022Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
15827764 | usd |
CY2021Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
11596781 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
22662895 | usd |
CY2021 | us-gaap |
Revenues
Revenues
|
19292087 | usd |
CY2022 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
11123857 | usd |
CY2021 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
9644761 | usd |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
11539038 | usd |
CY2021 | us-gaap |
Gross Profit
GrossProfit
|
9647326 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
12416893 | usd |
CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
10800944 | usd |
CY2022 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | usd |
CY2021 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
2498706 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
12416893 | usd |
CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
13299650 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-877855 | usd |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3652324 | usd |
CY2022 | us-gaap |
Interest Expense
InterestExpense
|
2149729 | usd |
CY2021 | us-gaap |
Interest Expense
InterestExpense
|
3657105 | usd |
CY2022 | us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
0 | usd |
CY2021 | us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
14889 | usd |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | usd |
CY2021 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-6105679 | usd |
CY2022 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-112139 | usd |
CY2021 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
0 | usd |
CY2022 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
2740820 | usd |
CY2021 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
0 | usd |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
478952 | usd |
CY2021 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-9747895 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-398903 | usd |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-13400219 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2041487 | usd |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2490295 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-2440390 | usd |
CY2021 | us-gaap |
Profit Loss
ProfitLoss
|
-15890514 | usd |
CY2022 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-97211 | usd |
CY2021 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
0 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2343179 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15890514 | usd |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.13 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.13 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
128128975 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
126664839 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
128128975 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
126664839 | shares |
CY2020Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-5395548 | usd |
CY2021 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
|
-25750 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
28500 | usd |
CY2021 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-6105679 | usd |
CY2021 | us-gaap |
Profit Loss
ProfitLoss
|
-15890514 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-15096820 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
281000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
8780 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
98448 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-2440390 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-17148982 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-2440390 | usd |
CY2021 | us-gaap |
Profit Loss
ProfitLoss
|
-15890514 | usd |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | usd |
CY2021 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-6105679 | usd |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
0 | usd |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
-25750 | usd |
CY2022 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
0 | usd |
CY2021 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
14889 | usd |
CY2022 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-112139 | usd |
CY2021 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
0 | usd |
CY2022 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
327509 | usd |
CY2021 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
2203234 | usd |
CY2022 | clsh |
Fair Value Of Shares Vested By Officers
FairValueOfSharesVestedByOfficers
|
8780 | usd |
CY2021 | clsh |
Fair Value Of Shares Vested By Officers
FairValueOfSharesVestedByOfficers
|
109313 | usd |
CY2022 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
2740820 | usd |
CY2021 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
0 | usd |
CY2022 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | usd |
CY2021 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
2498706 | usd |
CY2022 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
753740 | usd |
CY2021 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
685292 | usd |
CY2022 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
79847 | usd |
CY2021 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
15798 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-64361 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
539324 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
111056 | usd |
CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
28221 | usd |
CY2022 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
2189550 | usd |
CY2021 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
652810 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
0 | usd |
CY2021 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
-2500 | usd |
CY2022 | us-gaap |
Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
|
-324904 | usd |
CY2021 | us-gaap |
Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
|
-341035 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
709273 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
435742 | usd |
CY2022 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
235425 | usd |
CY2021 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
258113 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
0 | usd |
CY2021 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-150000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
2041487 | usd |
CY2021 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
2490295 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-40895 | usd |
CY2021 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
0 | usd |
CY2022 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-292424 | usd |
CY2021 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-379358 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3157670 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2535159 | usd |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1104806 | usd |
CY2021 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
269437 | usd |
CY2022 | us-gaap |
Payments For Construction In Process
PaymentsForConstructionInProcess
|
62045 | usd |
CY2021 | us-gaap |
Payments For Construction In Process
PaymentsForConstructionInProcess
|
0 | usd |
CY2022 | us-gaap |
Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
|
581714 | usd |
CY2021 | us-gaap |
Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
|
0 | usd |
CY2022 | us-gaap |
Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
|
2740820 | usd |
CY2021 | us-gaap |
Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
|
1544291 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
992255 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
1274854 | usd |
CY2022 | us-gaap |
Proceeds From Loans
ProceedsFromLoans
|
2322875 | usd |
CY2021 | us-gaap |
Proceeds From Loans
ProceedsFromLoans
|
0 | usd |
CY2022 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
1393966 | usd |
CY2021 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
0 | usd |
CY2022 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
10907 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
2500000 | usd |
CY2021 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
0 | usd |
CY2022 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
365991 | usd |
CY2021 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3052011 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
886596 | usd |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-1260305 | usd |
CY2021Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1665263 | usd |
CY2020Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2925568 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2551859 | usd |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1665263 | usd |
CY2022 | us-gaap |
Interest Paid Capitalized
InterestPaidCapitalized
|
1656774 | usd |
CY2021 | us-gaap |
Interest Paid Capitalized
InterestPaidCapitalized
|
943817 | usd |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | usd |
CY2021 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | usd |
CY2022 | us-gaap |
Interest Costs Capitalized
InterestCostsCapitalized
|
0 | usd |
CY2021 | us-gaap |
Interest Costs Capitalized
InterestCostsCapitalized
|
212601 | usd |
CY2022 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
281000 | usd |
CY2021 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
0 | usd |
CY2022 | us-gaap |
Stock Issued1
StockIssued1
|
0 | usd |
CY2021 | us-gaap |
Stock Issued1
StockIssued1
|
230470 | usd |
CY2022 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
229412 | usd |
CY2021 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
0 | usd |
CY2022 | us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
400795 | usd |
CY2021 | us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
0 | usd |
CY2022 | clsh |
Original Issue Discount On Notes Payable
OriginalIssueDiscountOnNotesPayable
|
1875000 | usd |
CY2021 | clsh |
Original Issue Discount On Notes Payable
OriginalIssueDiscountOnNotesPayable
|
0 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
98448 | usd |
CY2021 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
0 | usd |
CY2022 | us-gaap |
Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
|
0 | usd |
CY2021 | us-gaap |
Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
|
1172726 | usd |
CY2022 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 1</b> –<b> BUSINESS ORGANIZATION AND NATURE OF OPERATIONS</b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">CLS Holdings USA, Inc. (the “Company”) was originally incorporated as Adelt Design, Inc. (“Adelt”) on March 31, 2011 to manufacture and market carpet binding art. Production and marketing of carpet binding art never commenced.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On November 12, 2014, CLS Labs acquired 10,000,000 shares, or 55.6%, of the outstanding shares of common stock of Adelt from its founder, Larry Adelt. On that date, Jeffrey Binder, the Chairman, President and Chief Executive Officer of CLS Labs, was appointed Chairman, President and Chief Executive Officer of the Company. On November 20, 2014, Adelt adopted amended and restated articles of incorporation, thereby changing its name to CLS Holdings USA, Inc. Effective December 10, 2014, the Company effected a reverse stock split of its issued and outstanding common stock at a ratio of 1-for-0.625 (the “Reverse Split”), wherein 0.625 shares of the Company’s common stock were issued in exchange for each share of common stock issued and outstanding. As a result, 6,250,000 shares of the Company’s common stock were issued to CLS Labs in exchange for the 10,000,000 shares that it owned by virtue of the above-referenced purchase from Larry Adelt.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On April 29, 2015, the Company, CLS Labs and CLS Merger Inc., a Nevada corporation and wholly owned subsidiary of CLS Holdings (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) and completed a merger, whereby CLS Merger Inc. merged with and into CLS Labs, with CLS Labs remaining as the surviving entity (the “Merger”). Upon the consummation of the Merger, the shares of the common stock of CLS Holdings owned by CLS Labs were extinguished and the former stockholders of CLS Labs were issued an aggregate of 15,000,000 (post Reverse Split) shares of common stock in CLS Holdings in exchange for their shares of common stock in CLS Labs. As a result of the Merger, the Company acquired the business of CLS Labs and abandoned its previous business.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company has been issued a U.S. patent with respect to its proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into concentrates such as oils, waxes, edibles and shatter. These concentrates may be ingested in a number of ways, including through vaporization via electronic cigarettes (“e-cigarettes”), and used for a variety of pharmaceutical and other purposes. Internal testing of this extraction method and conversion process has revealed that it produces a cleaner, higher quality product and a significantly higher yield than the cannabinoid extraction processes currently existing in the marketplace. The Company has not commercialized its patented proprietary process or otherwise earned any revenues from it. The Company plans to generate revenues through licensing, fee-for-service and joint venture arrangements related to its patented proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into saleable concentrates.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On December 4, 2017, the Company and Alternative Solutions, entered into a Membership Interest Purchase Agreement (the “Acquisition Agreement”), as amended, for the Company to acquire the Oasis LLCs from Alternative Solutions. Pursuant to the Acquisition Agreement, the Company initially contemplated acquiring all of the membership interests in the Oasis LLCs from Alternative Solutions. Just prior to closing, the parties agreed that the Company would instead acquire all of the membership interests in Alternative Solutions, the parent of the Oasis LLCs, from its members, and the membership interests in the Oasis LLCs owned by members other than Alternative Solutions.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to the Acquisition Agreement, the Company paid a non-refundable deposit of $250,000 upon signing, which was followed by an additional payment of $1,800,000 paid in February 2018, for an initial 10% of each of the Oasis LLCs. At that time, the Company applied for regulatory approval to own an interest in the Oasis LLCs, which approval was received. On June 27, 2018, the Company made the payments to indirectly acquire the remaining 90% of the Oasis LLCs, which were equal to cash in the amount of $5,995,543, a $4.0 million promissory note due in December 2019 (the “Oasis Note”), and 22,058,823 shares of its common stock (the “Purchase Price Shares”) (collectively, the “Closing Consideration”). The cash payment of $5,995,543 was less than the $6,200,000 payment originally contemplated because the Company assumed an additional $204,457 of liabilities. The Company used the proceeds of a Canadian private securities offering to fund the cash portion of the Closing Consideration. The Company then applied for regulatory approval to own the additional 90% in membership interests in the Oasis LLCs, which it received on December 12, 2018. The Company received final regulatory approval to own its interest in the Oasis LLCs through Alternative Solutions under the revised structure of the transaction on April 26, 2022.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On October 31, 2018, the Company, CLS Massachusetts, Inc., a Massachusetts corporation and a wholly-owned subsidiary of the Company (“CLS Massachusetts”), and In Good Health, Inc., a Massachusetts corporation (“IGH”), entered into an Option Agreement (the “IGH Option Agreement”). Under the terms of the IGH Option Agreement, CLS Massachusetts had an exclusive option to acquire all of the outstanding capital stock of IGH (the “IGH Option”) during the period beginning on the earlier of the date that is one year after the effective date of the conversion and December 1, 2019 and ending on the date that was 60 days after such date. If CLS Massachusetts exercised the IGH Option, the Company, a wholly-owned subsidiary of the Company and IGH would enter into a merger agreement (the form of which had been agreed to by the parties) (the “IGH Merger Agreement”). At the effective time of the merger contemplated by the IGH Merger Agreement, CLS Massachusetts would pay a purchase price of $47,500,000, subject to reduction as provided in the IGH Merger Agreement, payable as follows: $35 million in cash, $7.5 million in the form of a five-year promissory note, and $5 million in the form of restricted common stock of the Company, plus $2.5 million as consideration for a non-competition agreement with IGH’s President, payable in the form of a five-year promissory note. IGH and certain IGH stockholders holding sufficient aggregate voting power to approve the transactions contemplated by the IGH Merger Agreement entered into agreements pursuant to which such stockholders, among other things, agreed to vote in favor of such transactions. On October 31, 2018, as consideration for the IGH Option, the Company made a loan to IGH, in the principal amount of $5,000,000, subject to the terms and conditions set forth in that certain loan agreement, dated as of October 31, 2018 between IGH as the borrower and the Company as the lender. The loan was evidenced by a secured promissory note of IGH, which bore interest at the rate of 6% per annum and was to mature on October 31, 2021. To secure the obligations of IGH to the Company under the loan agreement and the promissory note, the Company and IGH entered into a security agreement dated as of October 31, 2018, pursuant to which IGH granted to the Company a first priority lien on and security interest in all personal property of IGH. If the Company did not exercise the Option on or prior to the date that was 30 days following the end of the option period, the loan amount would be reduced to $2,500,000 as a break-up fee, subject to certain exceptions set forth in the IGH Option Agreement. On August 26, 2019, the parties amended the IGH Option Agreement to, among other things, delay closing until January 2020. By letter agreement dated January 31, 2020, the Company, CLS Massachusetts and IGH extended the IGH Option Agreement to February 4, 2020. On February 4, 2020, CLS Massachusetts exercised the IGH Option and IGH subsequently asserted that CLS Massachusetts’ exercise was invalid. By letter dated February 26, 2020, the Company informed IGH that as a result of its breaches of the IGH Option, which remained uncured, an event of default had occurred under the IGH Note. The Company advised IGH that it was electing to cause the IGH Note to bear interest at the default rate of 15% per annum effective February 26, 2020 and to accelerate all amounts due under the IGH Note. On February 27, 2020, IGH informed CLS Massachusetts that it did not plan to make further payments under the IGH Note on the theory that the break-up excused additional payments. This dispute, including whether IGH breached the IGH Option and whether CLS was entitled to collect default interest, was in litigation. During the twelve months ended May 31, 2021, the Company impaired the remaining amounts due under the IGH Note in the amount of $2,498,706, which included $2,497,884 in principal and $822 in accrued interest.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On June 14, 2021, the parties to the IGH lawsuit entered into a confidential settlement agreement to resolve the action and a secured promissory note dated and executed by IGH in favor of the Company effective on June 11, 2021 (the “IGH Settlement Note”). Pursuant to the IGH Settlement Note, IGH shall pay the Company $3,000,000, $500,000 of which was paid on or before June 21, 2021. A second payment of $500,000 was paid on or before July 12, 2021. The remaining $2,000,000 and accrued interest is being paid in 12 equal monthly installments beginning on August 12, 2021, pursuant to the terms of the promissory note. During the year ended May 31, 2022, the Company received $2,740,820 under the IGH Settlement Note, which includes $2,666,670 in principal and $74,150 in accrued interest. As of May 31, 2022, the amount due under the IGH Settlement Note was $166,667. The Company records amounts paid under the IGH Settlement Note as gains when payments are received.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On October 20, 2021, the Company entered into a management services agreement (the “Quinn River Joint Venture Agreement”) through its 50% owned subsidiary, Kealii Okamalu, LLC (“Kealii Okamalu”), with CSI Health MCD LLC (“CSI”) and a commission established by the authority of the Tribal Council of the Fort McDermitt Paiute and Shoshone Tribe (the “Tribe”). The purpose of the Quinn River Joint Venture Agreement is to establish a business (the “Quinn River Joint Venture”) to grow, cultivate, process and sell cannabis and related products. The Quinn River Joint Venture Agreement has a term of 10 years plus a 10 year renewal term from the date the first cannabis crop produced is harvested and sold. Pursuant to the Quinn River Joint Venture Agreement, Kealii Okamalu expects to lease approximately 20-30 acres of the Tribe’s land located along the Quinn River at a cost of $3,500 per quarter and manage the design, finance and construction of a cannabis cultivation facility on such tribal lands (the “Cultivation Facility”). Kealii Okamalu will also manage the ongoing operations of the Cultivation Facility and related business, including, but not limited to, cultivation of cannabis crops, personnel staffing, product packaging, testing, marketing and sales. Packaged products will be branded as “Quinn River Farms.” The Company will provide 10,000 square feet of warehouse space at its Las Vegas facility, and will have preferred vendor status including the right to purchase cannabis flower and the business’s cannabis trim at favorable prices. Kealii Okamalu is expected to contribute $6 million towards the construction of the Cultivation Facility and the working capital for the Quinn River Joint Venture. This amount will be repaid from a portion of the net income of the Quinn River Joint Venture otherwise payable to CSI and the Tribe at the rate of $750,000 per quarter for eight quarters. Kealii Okamalu will receive one-third of the net profits of the Quinn River Joint Venture.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On January 4, 2018, the former Attorney General, Jeff Sessions, rescinded the memorandum issued by former Deputy Attorney General James Cole on August 29, 2013 (as amended on February 14, 2014, the “Cole Memo”), the Cole Banking Memorandum, and all other related Obama-era DOJ cannabis enforcement guidance. While the rescission did not change federal law, as the Cole Memo and other DOJ guidance documents were not themselves laws, the rescission removed the DOJ’s formal policy that state-regulated cannabis businesses in compliance with the Cole Memo guidelines should not be a prosecutorial priority. Notably, former Attorney General Sessions’ rescission of the Cole Memo has not affected the status of the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (“FinCEN”) memorandum issued by the Department of Treasury, which remains in effect. This memorandum outlines Bank Secrecy Act-compliant pathways for financial institutions to service state-sanctioned cannabis businesses, which echoed the enforcement priorities outlined in the Cole Memo. In addition to his rescission of the Cole Memo, Attorney General Sessions issued a one-page memorandum known as the “Sessions Memorandum”. The Sessions Memorandum explains the DOJ’s rationale for rescinding all past DOJ cannabis enforcement guidance, claiming that Obama-era enforcement policies are “unnecessary” due to existing general enforcement guidance adopted in the 1980s, in chapter 9.27.230 of the U.A. Attorneys’ Manual (“USAM”). The USAM enforcement priorities, like those of the Cole Memo, are based on the use of the federal government’s limited resources and include “law enforcement priorities set by the Attorney General,” the “seriousness” of the alleged crimes, the “deterrent effect of criminal prosecution,” and “the cumulative impact of particular crimes on the community.” Although the Sessions Memorandum emphasizes that cannabis is a federally illegal Schedule I controlled substance, it does not otherwise instruct U.S. Attorneys to consider the prosecution of cannabis-related offenses a DOJ priority, and in practice, most U.S. Attorneys have not changed their prosecutorial approach to date. However, due to the lack of specific direction in the Sessions Memorandum as to the priority federal prosecutors should ascribe to such cannabis activities, there can be no assurance that the federal government will not seek to prosecute cases involving cannabis businesses that are otherwise compliant with state law.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">William Barr served as United States Attorney General from February 14, 2019 to December 23, 2020. The DOJ under Mr. Barr did not take a formal position on federal enforcement of laws relating to cannabis. On March 11, 2021, United States President Biden’s nominee, Merrick Garland was sworn in as the U.S. Attorney General. During his campaign, President Biden stated a policy goal to decriminalize possession of cannabis at the federal level, but he has not publicly supported the full legalization of cannabis. It is unclear what impact, if any, the new administration will have on U.S. federal government enforcement policy on cannabis. Nonetheless, there is no guarantee that the position of the Department of Justice will not change.</p> | |
CY2014Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.625 | pure |
CY2018Q1 | us-gaap |
Subsidiary Or Equity Method Investee Cumulative Percentage Ownership After All Transactions
SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
|
0.10 | pure |
CY2021 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
2498706 | usd |
CY2021Q2 | us-gaap |
Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
|
3000000 | usd |
CY2022 | us-gaap |
Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
|
2740820 | usd |
CY2021 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
2498706 | usd |
CY2022Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-95079817 | usd |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Use of Estimates</i></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> | |
CY2022 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Reclassification</i></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Certain amounts in the prior period have been reclassified to conform to the current period presentation.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> | |
CY2022Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2551859 | usd |
CY2021Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1665263 | usd |
CY2022 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
79847 | usd |
CY2021 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
15798 | usd |
CY2022 | us-gaap |
Advertising Expense
AdvertisingExpense
|
1453727 | usd |
CY2021 | us-gaap |
Advertising Expense
AdvertisingExpense
|
1237326 | usd |
CY2022 | us-gaap |
Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
|
Term of lease | |
CY2022Q2 | us-gaap |
Goodwill
Goodwill
|
557896 | usd |
CY2021Q2 | us-gaap |
Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
|
3000000 | usd |
CY2022 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-97200 | usd |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Concentrations of Credit Risk</i></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company maintains its cash in bank deposit accounts and other accounts, the balances of which at times may be uninsured or exceed federally insured limits. From time to time, some of the Company’s funds are also held by escrow agents; these funds may not be federally insured. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> | |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
17361 | usd |
CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
37122 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
22662895 | usd |
CY2021 | us-gaap |
Revenues
Revenues
|
19292087 | usd |
CY2022 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-112139 | usd |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
75306426 | shares |
CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
129623809 | shares |
CY2021Q2 | us-gaap |
Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
|
250069 | usd |
CY2022Q2 | us-gaap |
Other Receivables
OtherReceivables
|
0 | usd |
CY2021Q2 | us-gaap |
Other Receivables
OtherReceivables
|
10000 | usd |
CY2022Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
295869 | usd |
CY2021Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
262313 | usd |
CY2021 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
25185003 | usd |
CY2018Q4 | us-gaap |
Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
|
5000000 | usd |
CY2018Q4 | clsh |
Note Receivable Interest Rate Stated Percentage
NoteReceivableInterestRateStatedPercentage
|
0.06 | pure |
CY2022Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
618227 | usd |
CY2021Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
684935 | usd |
CY2022Q2 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
297563 | usd |
CY2021Q2 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
344085 | usd |
CY2022Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
3120039 | usd |
CY2021Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
883967 | usd |
CY2022Q2 | us-gaap |
Inventory Net
InventoryNet
|
3417602 | usd |
CY2021Q2 | us-gaap |
Inventory Net
InventoryNet
|
1228052 | usd |
CY2022Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2073449 | usd |
CY2021Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1434614 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4342434 | usd |
CY2021Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3475668 | usd |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1104806 | usd |
CY2021 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
269437 | usd |
CY2022Q2 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
2016 | usd |
CY2021Q2 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
2244 | usd |
CY2022Q2 | us-gaap |
Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
|
293853 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
638835 | usd |
CY2021 | us-gaap |
Depreciation
Depreciation
|
569278 | usd |
CY2020 | us-gaap |
Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
|
28511 | usd |
CY2021 | us-gaap |
Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
|
14899 | usd |
CY2022Q2 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P9Y | |
CY2022Q2 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
221469 | usd |
CY2019Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
4112876 | usd |
CY2022Q2 | us-gaap |
Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
|
1958359 | usd |
CY2022Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2154517 | usd |
CY2020Q4 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
14970 | usd |
CY2021 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
250000 | shares |
CY2021 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
215500 | usd |
CY2021Q2 | us-gaap |
Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
|
150000 | shares |
CY2019Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
4069476 | usd |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-1866069 | usd | |
CY2022Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2203407 | usd |
CY2022Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2203407 | usd |
CY2022Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2203407 | usd |
CY2022Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
309597 | usd |
CY2022Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1893810 | usd |
CY2022Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
493327 | usd |
CY2022Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
502461 | usd |
CY2022Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
515988 | usd |
CY2022Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
451671 | usd |
CY2022Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
227053 | usd |
CY2022Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
741756 | usd |
CY2022Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
2932256 | usd |
CY2022Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
728849 | usd |
CY2022Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
2203407 | usd |
CY2022Q2 | clsh |
Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
|
1663593 | usd |
CY2022Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
473308 | usd |
CY2022Q2 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
1190285 | usd |
CY2021Q2 | clsh |
Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
|
1663593 | usd |
CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
358403 | usd |
CY2021Q2 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
1305190 | usd |
CY2022 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
114905 | usd |
CY2021 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
116014 | usd |
CY2021Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
28500 | usd |
CY2021Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
28500 | usd |
CY2021 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-6105679 | usd |
CY2018Q4 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.8 | |
CY2022Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
114896 | usd |
CY2022Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
114896 | usd |
CY2022Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
114896 | usd |
CY2022Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
114896 | usd |
CY2022Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
114854 | usd |
CY2022Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
615847 | usd |
CY2022Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1190285 | usd |
CY2022Q2 | us-gaap |
Goodwill
Goodwill
|
557896 | usd |
CY2021Q2 | us-gaap |
Goodwill
Goodwill
|
557896 | usd |
CY2022Q2 | us-gaap |
Security Deposit
SecurityDeposit
|
229500 | usd |
CY2021Q2 | us-gaap |
Security Deposit
SecurityDeposit
|
167455 | usd |
CY2022Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
229500 | usd |
CY2021Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
167455 | usd |
CY2021Q1 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.3 | |
CY2018Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
8408400 | shares |
CY2021Q1 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
22516374 | shares |
CY2021Q1 | clsh |
Warrant Description
WarrantDescription
|
each warrant issuable pursuant to conversion of the Canaccord Debentures is exercisable for one share of the Company’s common stock at a price equal to $0.40 per share until March 31, 2024. | |
CY2022Q2 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
1414074 | usd |
CY2021Q2 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
771843 | usd |
CY2022Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
323254 | usd |
CY2021Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
279721 | usd |
CY2022Q2 | us-gaap |
Other Deferred Credits Current
OtherDeferredCreditsCurrent
|
580570 | usd |
CY2021Q2 | us-gaap |
Other Deferred Credits Current
OtherDeferredCreditsCurrent
|
557061 | usd |
CY2022Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2317898 | usd |
CY2021Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1608625 | usd |
CY2022 | us-gaap |
Proceeds From Loans
ProceedsFromLoans
|
2322875 | usd |
CY2022 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
1393966 | usd |
CY2022Q2 | us-gaap |
Debt Instrument Fee Amount
DebtInstrumentFeeAmount
|
84164 | usd |
CY2022Q2 | us-gaap |
Loans Payable
LoansPayable
|
1013073 | usd |
CY2022 | us-gaap |
Debt Instrument Term
DebtInstrumentTerm
|
P30D | |
CY2022 | clsh |
Discount Fee
DiscountFee
|
0.03 | pure |
CY2022 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
277017 | usd |
CY2021 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | usd |
CY2021Q2 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
6229672 | usd |
CY2021Q4 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.8 | |
CY2021Q2 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.3 | |
CY2021Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
3893545 | shares |
CY2022Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
19448821 | usd |
CY2022Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
1250000 | usd |
CY2022Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
1250000 | usd |
CY2022Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
375000 | usd |
CY2022Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
|
375000 | usd |
CY2022Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
|
1125000 | usd |
CY2022Q2 | us-gaap |
Long Term Debt
LongTermDebt
|
23823821 | usd |
CY2022 | clsh |
Debenture Offering Maximum
DebentureOfferingMaximum
|
5500000 | usd |
CY2022Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.4125 | |
CY2022 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
2500000 | usd |
CY2022 | clsh |
Class Of Warrant Or Rights Granted
ClassOfWarrantOrRightsGranted
|
3030304 | shares |
CY2021Q2 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | usd |
CY2022Q2 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
12204928 | usd |
CY2021Q2 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
7457218 | usd |
CY2019Q1 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P18M | |
CY2021Q4 | us-gaap |
Area Of Real Estate Property
AreaOfRealEstateProperty
|
20 | acre |
CY2022Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
359900 | usd |
CY2022Q1 | us-gaap |
Lessor Direct Financing Lease Variable Lease Payment Terms And Conditions
LessorDirectFinancingLeaseVariableLeasePaymentTermsAndConditions
|
forty-eight monthly installments of $10,173 | |
CY2022Q2 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.1589 | pure |
CY2022 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
10907 | usd |
CY2022 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
9439 | usd |
CY2022Q2 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
348993 | usd |
CY2021Q2 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
0 | usd |
CY2022Q2 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
348993 | usd |
CY2021Q2 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
0 | usd |
CY2022Q2 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
71813 | usd |
CY2021Q2 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
0 | usd |
CY2022Q2 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
277180 | usd |
CY2021Q2 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
0 | usd |
CY2022Q2 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
348993 | usd |
CY2021Q2 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
0 | usd |
CY2021Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
10382785 | shares |
CY2021Q2 | clsh |
Warrant Description
WarrantDescription
|
each warrant issuable pursuant to conversion of such debentures is exercisable for one share of the Company’s common stock at a price equal to 137.5% of the conversion price (presently $0.4125 per share) until July 14, 2024 | |
CY2022Q2 | us-gaap |
Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
|
71813 | usd |
CY2022Q2 | us-gaap |
Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
|
84064 | usd |
CY2022Q2 | us-gaap |
Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
|
98405 | usd |
CY2022Q2 | us-gaap |
Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
|
94711 | usd |
CY2022Q2 | us-gaap |
Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
|
0 | usd |
CY2022Q2 | us-gaap |
Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
|
0 | usd |
CY2022Q2 | us-gaap |
Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
|
348993 | usd |
CY2021Q4 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P9Y | |
us-gaap |
Loss Contingency Accrual Provision
LossContingencyAccrualProvision
|
10000 | usd | |
CY2022 | us-gaap |
Loss Contingency Disclosures
LossContingencyDisclosures
|
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOTE 19</b> –<b> CONTINGENT LIABILITY</b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The terms of the Company’s acquisition of Alternative Solutions, included a payment of $1,000,000 contingent upon the Oasis LLCs achieving certain revenue targets. (see note 3). The fair value of this contingent consideration at the time of the Acquisition Agreement was $678,111 as determined by the Company’s outside valuation consultants. Management reviewed the value of the contingent consideration, and concluded that, due to the increased revenue of Alternative Solutions, the fair value of this contingent liability was $1,000,000 at May 31, 2019. The Company recorded a charge to operations in the amount of $321,889 during the year ended May 31, 2019.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The full amount of the bonus payment was earned, and on May 27, 2020, the Company made a payment in the amount of $850,000 to the sellers. The Company deposited the balance due to sellers of $150,000 with an escrow agent to hold pending the outcome of a tax audit. During the year ended May 31, 2020, the State of Nevada notified the Oasis LLCs that it would be conducting a tax audit for periods both before and after the closing of the sale to CLS. The tax audit was completed and the Company received a deficiency notice dated January 29, 2021. The Company paid the tax due and on February 16, 2021, $41,805 of the escrowed amount was released to the Company, $106,195 was released to sellers and the balance of $2,000 was remitted to the escrow agent as payment of its fees.</p> | |
CY2019Q2 | us-gaap |
Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
|
1000000 | usd |
CY2018Q2 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
678111 | usd |
CY2019 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
321889 | usd |
CY2020Q2 | us-gaap |
Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
|
850000 | usd |
CY2021Q1 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
106195 | usd |
CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
750000000 | shares |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
128208082 | shares |
CY2021Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
127221416 | shares |
CY2021Q3 | us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
936666 | shares |
CY2021Q3 | clsh |
Class Of Warrant Or Rights Granted
ClassOfWarrantOrRightsGranted
|
468333 | shares |
CY2021Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1.1 | |
CY2021Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.4 | |
CY2021Q3 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
281000 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
|
50000 | shares |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
4390 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
|
50000 | shares |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
4390 | usd |
CY2022 | us-gaap |
Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
|
50000 | shares |
CY2022 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
4390 | usd |
CY2022 | clsh |
Number Of Shares To Be Issued
NumberOfSharesToBeIssued
|
50000 | shares |
CY2020Q4 | us-gaap |
Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
|
50000 | shares |
CY2022Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
2500000 | usd |
CY2022Q1 | clsh |
Class Of Warrant Or Rights Granted
ClassOfWarrantOrRightsGranted
|
3030304 | shares |
CY2022Q1 | clsh |
Warrant Description
WarrantDescription
|
Each warrant allows the holder to purchase one share of the Company’s common stock at an exercise price of $0.4125 per share for three years after its date of issuance | |
CY2022Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.4125 | |
CY2022Q1 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P3Y | |
CY2022Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
6451339 | shares |
CY2022 | clsh |
Warrants Outstanding Weighted Average Remaining Contractual Term
WarrantsOutstandingWeightedAverageRemainingContractualTerm
|
P1Y5M12D | |
CY2022 | clsh |
Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Outstanding
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding
|
0.5 | |
CY2022 | clsh |
Class Of Warrant Or Rights Exercisable
ClassOfWarrantOrRightsExercisable
|
6451339 | shares |
CY2022 | clsh |
Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Exercisable
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercisable
|
0.5 | |
CY2020Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
54835145 | shares |
CY2020Q2 | clsh |
Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Outstanding
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding
|
0.53 | |
CY2021 | clsh |
Granted Number Of Shares
GrantedNumberOfShares
|
0 | shares |
CY2021 | clsh |
Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Granted
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsGranted
|
1.1 | |
CY2021 | clsh |
Class Of Warrant Or Rights Exercised
ClassOfWarrantOrRightsExercised
|
0 | shares |
CY2021 | clsh |
Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Exercised
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercised
|
0 | |
CY2021 | clsh |
Class Of Warrant Or Rights Cancelled Expired
ClassOfWarrantOrRightsCancelledExpired
|
-837500 | shares |
CY2021 | clsh |
Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Cancelled Expired
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsCancelledExpired
|
0.75 | |
CY2021Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
53997645 | shares |
CY2021 | clsh |
Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Outstanding
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding
|
0.53 | |
CY2022 | clsh |
Granted Number Of Shares
GrantedNumberOfShares
|
3030304 | shares |
CY2022 | clsh |
Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Granted
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsGranted
|
0.41 | |
CY2022 | clsh |
Class Of Warrant Or Rights Exercised
ClassOfWarrantOrRightsExercised
|
0 | shares |
CY2022 | clsh |
Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Exercised
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsExercised
|
0 | |
CY2022 | clsh |
Class Of Warrant Or Rights Cancelled Expired
ClassOfWarrantOrRightsCancelledExpired
|
-50576610 | shares |
CY2022 | clsh |
Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Cancelled Expired
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsCancelledExpired
|
0.52 | |
CY2022Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
6451339 | shares |
CY2022 | clsh |
Class Of Warrant Or Rights Weighted Average Exercise Price Of Warrants Or Rights Outstanding
ClassOfWarrantOrRightsWeightedAverageExercisePriceOfWarrantsOrRightsOutstanding
|
0.5 | |
CY2018Q1 | clsh |
Class Of Warrant Or Rights Granted
ClassOfWarrantOrRightsGranted
|
205238 | shares |
CY2018Q2 | clsh |
Warrants Issued Price Per Warrant
WarrantsIssuedPricePerWarrant
|
0.45 | |
CY2022Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
0 | usd |
CY2021Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
0 | usd |
CY2022 | us-gaap |
Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
|
100000 | shares |
CY2022 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
8780 | usd |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
50000 | shares |
CY2022 | us-gaap |
Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
|
50000 | shares |
CY2022 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
4390 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
22662895 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-12941530 | usd |
CY2022 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
9721365 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.21 | pure |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2041487 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2022Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
2563035 | usd |
CY2021Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
1566016 | usd |
CY2022Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
2563035 | usd |
CY2021Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
1566016 | usd |
CY2022Q2 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | usd |
CY2021Q3 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P3Y | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001522222 |